The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population
Open accessAbstract
OBJECTIVE—The purpose of this study was to evaluate whether insulin resistance is associated to cardiovascular disease (CVD) and to understand whether this association can be explained by traditional and novel CVD risk factors associated with this metabolic disorder. RESEARCH DESIGN AND METHODS—We examined a sample representative of the population of Bruneck, Italy (n = 919; aged 40–79 years). Insulin-resistant subjects were those with a score in the top quartile of the homeostasis model assessment (HOMA) for insulin resistance (HOMA-IR). Risk factors correlated with insulin resistance included BMI, A1C, HDL cholesterol, triglycerides, blood pressure, high-sensitivity C-reactive protein (hsCRP), fibrinogen, oxidized LDL, vascular cell adhesion molecule-1 (VCAM-1), and adiponectin. Subjects without CVD at baseline were followed up for 15 years for incident CVD, a composite end point including fatal and nonfatal myocardial infarction and stroke, transient ischemic attack, and any revascularization procedure. RESULTS—During follow-up, 118 subjects experienced a first symptomatic CVD event. Levels of HOMA-IR were higher at baseline among subjects who developed CVD (2.8) compared with those remaining free of CVD (2.5) (P < 0.05). Levels of HOMA-IR also were significantly correlated (P < 0.05) with most CVD risk factors we evaluated. In Cox proportional hazard models, insulin-resistant subjects had an age-, sex-, and smoking-adjusted 2.1-fold increased risk (95% CI 1.3–3.1) of incident symptomatic CVD relative to non–insulin-resistant subjects. After sequential adjustment for physical activity and classic risk factors (A1C, LDL cholesterol, and hypertension) as well as BMI, HDL cholesterol, triglycerides, and novel risk factors, including fibrinogen, oxidized LDL, hsCRP, VCAM-1, and adiponectin, the association between HOMA-IR and incident CVD remained significant and virtually unchanged (hazard ratio 2.2 [95% CI 1.4–3.6], P < 0.001). CONCLUSIONS—HOMA-estimated insulin resistance is associated with subsequent symptomatic CVD in the general population independently of all classic and several nontraditional risk factors. These data suggest that insulin resistance may be an important target to reduce CVD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Self-citationWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Self-citationZiccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 837
Self-citationZavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Self-citationKuboki, K., Jiang, Z. Y., Takahara, N., Ha, S. W., Igarashi, M., Yamauchi, T., Feener, E. P., Herbert, T. P., Rhodes, C. J., & King, G. L. (2000) · Circulation · doi:10.1161/01.cir.101.6.676 · Cited by 639
Hanley, A. J. G., Williams, K., Stern, M. P., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1177 · Cited by 637
Phillips, D. I. W., Clark, P. M., Hales, C. N., & Osmond, C. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00273.x · Cited by 631
Short, K. R., Vittone, J. L., Bigelow, M. L., Proctor, D. N., Rizza, R. A., Coenen-Schimke, J. M., & Nair, K. S. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1888 · Cited by 631
Bonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604
Self-citationResnick, H. E., Jones, K., Ruotolo, G., Jain, A. K., Henderson, J., Lu, W., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.861 · Cited by 427
Nonhypoglycemic Effects of Thiazolidinediones
Parulkar, A. A., Pendergrass, M. L., Granda-Ayala, R., Lee, T. R., & Fonseca, V. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00014 · Cited by 412
O'dea, K. (1984) · Diabetes · doi:10.2337/diab.33.6.596 · Cited by 412
Federici, M., Menghini, R., Mauriello, A., Hribal, M. L., Ferrelli, F., Lauro, D., Sbraccia, P., Spagnoli, L. G., Sesti, G., & Lauro, R. (2002) · Circulation · doi:10.1161/01.cir.0000023043.02648.51 · Cited by 373
Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease
Yip, J. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2773 · Cited by 360
Nagi, D. K., & Yudkin, J. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.4.621 · Cited by 353
Vascular function, insulin resistance and fatty acids
Steinberg, H., & Baron, A. (2002) · Diabetologia · doi:10.1007/s00125-002-0800-2 · Cited by 341
Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Bonadonna, R. C., & Muggeo, M. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1251 · Cited by 332
Self-citationPhysical activity decreases cardiovascular disease risk in women
Oguma, Y., & Shinoda-Tagawa, T. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.02.007 · Cited by 323
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol
Robins, S. J., Rubins, H. B., Faas, F. H., Schaefer, E. J., Elam, M. B., Anderson, J. W., Collins, D., & on behalf of the VA-HIT Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1513 · Cited by 308
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3252 · Cited by 307
Self-citationPopulation-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1782 · Cited by 270
Self-citationLangenfeld, M. R., Forst, T., Hohberg, C., Kann, P., Lübben, G., Konrad, T., Füllert, S. D., Sachara, C., & Pfützner, A. (2005) · Circulation · doi:10.1161/01.cir.0000165072.01672.21 · Cited by 264
Jouven, X., Charles, M.-A., Desnos, M., & Ducimetière, P. (2001) · Circulation · doi:10.1161/hc3201.094151 · Cited by 256
Choi, D., Kim, S.-K., Choi, S.-H., Ko, Y.-G., Ahn, C.-W., Jang, Y., Lim, S.-K., Lee, H.-C., & Cha, B.-S. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2654 · Cited by 243
Insulin resistance and coronary artery disease
Bressler, P., Bailey, S. R., Matsuda, M., & DeFronzo, R. A. (1996) · Diabetologia · doi:10.1007/s001250050581 · Cited by 226
Insulin Attenuates the Systemic Inflammatory Response in Endotoxemic Rats
Jeschke, M. G., Klein, D., Bolder, U., & Einspanier, R. (2004) · Endocrinology · doi:10.1210/en.2004-0592 · Cited by 217
Asymptomatic atherosclerosis and insulin resistance.
Laakso, M., Sarlund, H., Salonen, R., Suhonen, M., Pyörälä, K., Salonen, J. T., & Karhapää, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.1068 · Cited by 206
Hedblad, B., Nilsson, P., Engström, G., Berglund, G., & Janzon, L. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00719.x · Cited by 203
Hak, A. E., Pols, H. A. P., Stehouwer, C. D. A., Meijer, J., Kiliaan, A. J., Hofman, A., Breteler, M. M. B., & Witteman, J. C. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7873 · Cited by 184
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Bonadonna, R. C., & Muggeo, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802381 · Cited by 184
Self-citationWilleit, J., & Kiechl, S. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.5.661 · Cited by 176
Self-citationDifferential effects of insulin deficiency on albumin and fibrinogen synthesis in humans.
De Feo, P., Gaisano, M. G., & Haymond, M. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115384 · Cited by 174
Insulin infusion in acute illness
Dandona, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26045 · Cited by 147
Bonora, E., Tessari, R., Micciolo, R., Zenere, M. B., Targher, G., Padovani, R., Falezza, G., & Muggeo, M. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.627 · Cited by 143
Self-citationInsulin Directly Reduces Platelet Sensitivity to Aggregating Agents: Studies In Vitro and In Vivo
Trovati, M., Anfossi, G., Cavalot, F. L., Massucco, P., Mularoni, E., & Emanuelli, G. (1988) · Diabetes · doi:10.2337/diab.37.6.780 · Cited by 125
Zethelius, B., Lithell, H., Hales, C. N., & Berne, C. (2005) · Diabetologia · doi:10.1007/s00125-005-1711-9 · Cited by 111
Matsumoto, K., Sera, Y., Abe, Y., Ueki, Y., Tominaga, T., & Miyake, S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00198-9 · Cited by 70
Yudkin, J. S., May, M., Elwood, P. C., YARNELL, J. W. G., Greenwood, R., & Smith, G. D. (2002) · Diabetologia · doi:10.1007/s00125-001-0756-7 · Cited by 69
Carantoni, M., Abbasi, F., Warmerdam, F. A. R. M., Klebanov, M., Wang, P., Chen, Y. I., Azhar, S., & Reaven, G. M. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.5.762 · Cited by 65
Insulin Inhibits Migration of Vascular Smooth Muscle Cells With Inducible Nitric Oxide Synthase
Kahn, A. M., Allen, J. C., Seidel, C. L., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.303 · Cited by 45
Adler, A., Lévy, J., Matthews, D. R., STRATTON, I. M., Hines, G., & Holman, R. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01418.x · Cited by 39
Nagi, D. K., Tracy, R. P., & Pratley, R. E. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90242-5 · Cited by 25
Cited by
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
DeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Ortega, F. B., Lee, D.-C., Katzmarzyk, P. T., Ruiz, J. R., Sui, X., Church, T. S., & Blair, S. N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs174 · Cited by 468
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Meshkani, R., & Adeli, K. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.018 · Cited by 458
Metadata
- Authors
- Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-02-01
- Volume
- 30
- Issue
- 2
- Pages
- 318-324
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2156302492
- Cited by
- 343
- References
- 52
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.